JAX, in collaboration with several Maine regional hospitals, will provide additional coronavirus testing capacity for frontline health care workers and in-patients in the state of Maine.
Headquartered in Bar Harbor, the nonprofit research institution whose mission is to improve human health, is dedicated to helping both the global biomedical community as well as its local communities. Beginning Tuesday, April 14, JAX will collaborate with hospitals in Maine, including MaineGeneral Medical Center in Augusta, Mount Desert Island (MDI) Hospital in Bar Harbor, and Northern Light Maine Coast Hospital in Ellsworth to augment their existing testing capacity for their health care workers and in-patients who are symptomatic for COVID-19. Testing for COVID-19 infection is a critical element for pandemic control and has been in short supply.
JAX’s Connecticut-licensed CLIA (Clinical Laboratory Improvement Amendments) and CAP accredited laboratory in Farmington, Connecticut tests patient samples for a specific RNA signature unique to SARS-CoV-2, the virus that causes COVID-19. As the COVID-19 pandemic evolves, JAX is adopting advanced technologies and new assay platforms and will make these available to its partnering hospitals and health care facilities. Read more
